Our research is the first demonstration that SHIP can indirectly regulate the expression of Trib1 through altering STAT5 activation to mediate the function of macrophages, which may provide significant insight into development of novel therapeutics to conquer bacterial infection. Here, TRIB1 is linked to bacterial infectious disease.